Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2010
02/04/2010US20100029690 Nitrogen-containing heterocyclic compounds
02/04/2010US20100029689 Phosphodiesterase 4 inhibitors
02/04/2010US20100029688 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment
02/04/2010US20100029687 Piperidine derivative or salt thereof
02/04/2010US20100029686 Hcv protease inhibitors and uses thereof
02/04/2010US20100029685 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
02/04/2010US20100029684 Pyrazinone Modulator of Corticotropin-Releasing Factor Receptor Activity
02/04/2010US20100029683 Methods for regulating cell mitosis by inhibiting serine/threonine phosphateses
02/04/2010US20100029682 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same
02/04/2010US20100029681 Heterocyclic compounds as calcium channel blockers
02/04/2010US20100029680 Certain Chemical Entities, Compositions and Methods
02/04/2010US20100029679 Antibacterial quinoline derivatives
02/04/2010US20100029678 Diuretics
02/04/2010US20100029677 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
02/04/2010US20100029676 T315a and f317i mutations of bcr-abl kinase domain
02/04/2010US20100029675 Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use
02/04/2010US20100029674 Methods of Using Phosphoantigen for the Treatment of Cancer
02/04/2010US20100029673 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use
02/04/2010US20100029672 Method of treating liver disease
02/04/2010US20100029671 Heterocyclic Compounds And Uses Thereof In The Treatment Of Sexual Disorders
02/04/2010US20100029670 Organic compounds
02/04/2010US20100029669 3-(substituted ethyl)-rifamycin derivatives useful as antimicrobial agents
02/04/2010US20100029667 Spray dried formulation
02/04/2010US20100029666 Macrocyclic Quinoxaline Compounds as HCV NS3 Protease Inhibitors
02/04/2010US20100029665 Methods and Compositions for Treating Migraine Pain
02/04/2010US20100029664 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
02/04/2010US20100029663 Compositions and methods for reducing activation of alpha-1 receptors
02/04/2010US20100029662 Vasoconstriction compositions and methods of use
02/04/2010US20100029661 Anesthetic compositions and methods of use
02/04/2010US20100029660 Compositions and methods for reversing rebound hyperemia
02/04/2010US20100029659 Preferential vasoconstriction compositions and methods of use
02/04/2010US20100029658 Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof
02/04/2010US20100029657 Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
02/04/2010US20100029656 Azabicyclic heterocycles as cannabinoid receptor modulators
02/04/2010US20100029655 Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them
02/04/2010US20100029654 Cardiovascular compositions and use of the same for the treatment of alzheimer's disease
02/04/2010US20100029653 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders
02/04/2010US20100029652 Combination Therapy For Treating Hepatitis C Infections
02/04/2010US20100029651 Aryl-substituted heterocycles, and use thereof
02/04/2010US20100029650 Bicyclic compounds and use as antidiabetics
02/04/2010US20100029649 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
02/04/2010US20100029648 11-Beta HSD1 Inhibitors
02/04/2010US20100029647 3,4,(5)-substituted tetrahydrophyridines
02/04/2010US20100029646 Prodrugs of diphenyl ox-indol-2-one compounds
02/04/2010US20100029645 Inhibitors of Cytosolic Phospholipase A2
02/04/2010US20100029644 Compounds Which Modulate The CB2 Receptor
02/04/2010US20100029643 Heterocyclyc sulfonamides having edg-1 antagonistic activity
02/04/2010US20100029642 Methods of Using Pyridodihydropyrazinones
02/04/2010US20100029641 Aryl sulfamide derivatives and methods of their use
02/04/2010US20100029640 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
02/04/2010US20100029639 Ion channel modulating compounds and uses thereof
02/04/2010US20100029638 Fused heterocyclyc inhibitor compounds
02/04/2010US20100029637 Chymase Inhibitors
02/04/2010US20100029636 Lck inhibitors
02/04/2010US20100029635 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
02/04/2010US20100029634 Chemokine Receptor Modulators
02/04/2010US20100029633 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
02/04/2010US20100029632 improved pharmacokinetics
02/04/2010US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
02/04/2010US20100029630 Reverse-turn mimetics and method relating thereto
02/04/2010US20100029629 Acyclic compounds having 5-ht6 receptor affinity
02/04/2010US20100029628 2,4,5-Substituted Piperidines as Renin Inhibitors
02/04/2010US20100029627 Mtki quinazoline derivatives
02/04/2010US20100029626 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
02/04/2010US20100029625 Therapeutic Agent for Restenosis
02/04/2010US20100029624 Male Contraceptive
02/04/2010US20100029623 4-(1-amino-ethyl)-cyclohexylamine derivatives
02/04/2010US20100029622 Microemulsions
02/04/2010US20100029621 Hexafluoroisopropanol derivatives
02/04/2010US20100029620 Substituted triazoline, tetrazolone and imidazolone derivatives for use as a medicine
02/04/2010US20100029619 Fused heterocyclic compound
02/04/2010US20100029618 Alpha-2 receptor pan agonist and anticonvulsant compositions for treating chronic pain
02/04/2010US20100029617 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists
02/04/2010US20100029616 Urotensin ii receptor antagonists
02/04/2010US20100029615 Benzimidazole derivatives
02/04/2010US20100029614 Spirocyclic heterocyclic derivatives and methods of their use
02/04/2010US20100029613 Treatment and prevention of epilepsy
02/04/2010US20100029612 2-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands
02/04/2010US20100029611 Sphingosine-1-phosphate (S1P) receptor modulating agents such as 1-((3-fluoro-4-(5(1-phenylcyclopropyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)methyl)azetidine-3-carboxylic acid, used for the treatment of autoimmune diseases; side effect reduction
02/04/2010US20100029610 Heteroaryl Compounds and Uses Thereof
02/04/2010US20100029609 Biaryl sulfonamide derivatives
02/04/2010US20100029608 Histamine H3 Receptor Agents, Preparation and Therapeutic Uses
02/04/2010US20100029607 Substituted Piperazines as CB1 Antagonists
02/04/2010US20100029606 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
02/04/2010US20100029605 Compounds and compositions as protein kinase inhibitors
02/04/2010US20100029604 Antibacterial combination and its use
02/04/2010US20100029603 16alpha-methyl or ethyl substituted estrogens
02/04/2010US20100029602 Low-dose mometasone formulations
02/04/2010US20100029601 Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
02/04/2010US20100029600 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
02/04/2010US20100029599 Indolylamides as modulators of the EP2 receptor
02/04/2010US20100029598 Extended Benzamide Derivatives as Modulators of the EP2 Receptor
02/04/2010US20100029597 Reca inhibitors with antibiotic activity, compositions and methods of use
02/04/2010US20100029596 Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonate
02/04/2010US20100029595 Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt
02/04/2010US20100029594 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
02/04/2010US20100029593 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
02/04/2010US20100029592 Deuterium-enriched fosaprepitant
02/04/2010US20100029591 Combinations of a pyrimidine containing nnrti with rt inhibitors
02/04/2010US20100029590 Methods for treating or preventing hemorrhagic cystitis using a glycerophosphate salt
1 ... 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 ... 7860